|
Market Closed -
Nasdaq
16:30:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 1.530 USD | -2.55% |
|
+5.52% | -77.16% |
| 25-09-11 | GRI Bio Says Data Show No Lung Function Decline in Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis | MT |
| 25-04-01 | GRI Bio Prices up to $13 Million Equity Offering | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E |
|---|
- Stock Market
- Stocks
- GRI Stock
- Charts GRI BIOPAR
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
